雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

A CONSIDERATION ON PHARMACOKINETICS OF A NEW WATER-SOLUBLE ANTI-TUMOR NITROSOUREA, ACNU, IN PATIENTS WITH MALIGNANT BRAIN TUMOR Teruaki Mori 1 , Katsuyoshi Mineura 1 , Ryuichi Katakura 1 1Division of Neurosurgery, Institute of Brain Diseases, Tohoku University School of Medicine pp.601-606
Published Date 1979/6/1
DOI https://doi.org/10.11477/mf.1406204426
  • Abstract
  • Look Inside

For the purpose of treatment of brain tumor with ACNU1,21), 1-(4-amino-2 methylpyrimidin-5- yl) methyl-3-(2-chloroethyl)-3-nitrosourea hydro-chloride, it was examined to correlate of perme-ability in blood-brain-barrier (B. B. B.) with its pharmacokinetics of ACNU.

ACNU 100-150 mg/boby was injected intra-venously into 14 cases of brain tumor. Transition of ACNU into cerebrospinal fluid (CSF) was noted after 5 minutes, showing the maximum value of 0.59 ±0.13 μg/ml after 30 min.

The pharmacokinetic analysis in CSF level was performed according to the one compartment model BMDP 3R Non-Iinear Regression Program3) (Fig. 2) using an IBM 370/125 Computer. The following formula (1) was simulately established from the relation of CSF level with time (hr), and the transition rate constant (kt) and elimination rate constant (ke1) were then calculated.

Cp=kt/kt-ke1 A0(e-ke1・t-e-kt・t)……………( 1 )

Consequently, kt = 1. 85 hr- and ke1 =1. 42 hr- were obtained. The half-life (t 1/2) in CSF (ventricle) was estimated at O. 49 hr. The maximum concen-tration in the ventricle was approximately 1 μgml achieved at 37 mins. after the intravenous injection, indicating the transition to be considerably slower in comparison with other tissues. Furthermore, kel coincided closely with the blood level, sug-gesting some degree of transition had occurred from the blood to CSF.

The phamacokinetic analysis in blood level was performed according to the two compartment open model7). The drug-concentration in the central compartment (blood and organs having the same behavior as blood) can be described as the following formula (2), where V1 is the distribution volume of central compartment, V2=distribution volume of tissue compartment (all tissues other than central compartment), k12 and k21 =transition rate constant between the two compartments and ke1=elimination rate constant from the central compartment.

Cp=Ae-αt+Be-βt…………… ( 2 )

Values of A, B, α and β to complete the above formula were obtained from blood levels and times (hr), and k12, k21, ke1, V1, V2, t/2 (half life) and [AUC]0 were then calculated referring to these known parameters. From the above results, it can be concluded with respect to the in vivo behavior of ACNU i. v. as follows :

(1) The distribution rate is extremely rapid, with half-life of a-phase (αt/2) being 1.3 minutes (0.021 hr).

(2) The elimination rate is also relatively rapid having half life (βt/2) of 35 minutes (0.58 hr).

(3) In comparisons of rate constants, the order was revealed to be k12 kel k21 in individual cases except for Model-I.

(4) In distribution volume, V2 was larger than V1 indicating its higher transition into the tissue compartment.

It is concluded that ACNU transits well into CSF. The authors therefore expect ACNU to be valuable for the treatment of brain tumors.


Copyright © 1979, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 2185-405X 印刷版ISSN 0006-8969 医学書院

関連文献

  • 制癌剤 宮永 直人 , 赤座 英之 医学書院 臨床泌尿器科
    53巻 2号 (1999年2月)
    pp.123-130
    • 有料閲覧
  • 制癌剤 竹内 正七 医学書院 臨床婦人科産科
    20巻 9号 (1966年9月)
    pp.695-701
    • 有料閲覧
  • 制癌剤 宇塚 善郎 医学書院 病院
    34巻 4号 (1975年4月)
    pp.62-63
    • 有料閲覧
  • 制癌剤 佐藤 靖雄 , 森田 守 , 渡辺 哲敏 医学書院 耳鼻咽喉科
    40巻 10号 (1968年10月)
    pp.817-825
    • 有料閲覧
  • 制癌剤 小川 一誠 医学書院 臨床泌尿器科
    47巻 4号 (1993年3月)
    pp.37-39
    • 有料閲覧
もっと見る

文献を共有